Maayke Hunfeld

63 Review neuromonitoring Outcome Score Follow up interval Results Mortality (%) Limitations Grade -Primary: Mortality -Secondary: PCPC (-1-2-3= good and no worsening from baseline score=good outcome) Hospital discharge -All 28 patients with normal CT survived with good outcome (P<0.001, PPV 86%, NPV 70%) -At least 1 CT abnormality associated with mortality and poor outcome (P<0.001) -Quantative and qualitative loss of GWM differentiation associated with mortality and poor outcome (P<0.001, PPV mortality 91% and poor outcome 100%) -Basilar cistern effacement and sulcal effacement associated with mortality and poor outcome (resp P=0.001 and P<0.001, PPV mortality resp 97% and 100% and poor outcome resp 93% and 100%) -reversal sign associated with mortality and poor outcome (P=0.011, PPV mortality and poor outcome 100%) 50% -Retrospective -CT performed when clinically indicated -Crude secondary outcome scale at hospital discharge -Clinicians non blinded for CT results 2B PCPC (1-2-3=good outcome) Hospital discharge -Decrease in GWR-basal ganglia and average associated with poor outcome (rep P 0.005 and 0.04) -Decrease in GWR- CN/PIC, CN/CC and PU/CC (resp P0.03, 0.006 and 0.004) -Ambient cistern effacement associated with poor outcome(P<0.001) Unspecified -Retrospective -CT performed when clinically indicated -Crude secondary outcome scale at hospital discharge -Clinicians non blinded for CT results 2B 2